On the heels of the repurposing of FKBP12-rapamycin with a novel synthetic molecular glue (left), we now have the repurposing of cyclophilin–CsA (center) to target KRAS G12C with another synthetic glue (right)
https://t.co/WiXFvLBDzW
Please check out our review!
'Structural Aspects of #LIMK Regulation and Pharmacology'
https://t.co/zFn1Z9xTNQ
Thanks everyone for your contributions @chatterjeedeep@VerenaD4 @thesgcfrankfurt @MDPIOpenAccess